qMate Mini Nucleic Acid Extraction System
Hemopathies
Mutation-Targeted Testing
Key Advantages and Benefits
1.Comprehensive Multi-Gene Coverage
Detects critical mutations in BCL2, BTK, PLCG2, MYD88, and CXCR4/CD79b, enabling a holistic assessment of resistance mechanisms in hematologic malignancies.
2.Precision Therapy Guidance
Identifies resistance to targeted drugs (e.g., Venetoclax, Ibrutinib), supporting personalized treatment decisions and improving therapeutic efficacy.
3.Prognostic & Monitoring Value
Helps track disease progression and predict patient outcomes by linking mutations to survival rates and treatment response.
4.Clinically Actionable Insights
Provides evidence-based molecular data for oncologists, though results should be integrated with other clinical findings for optimal decision-making.
5.Efficiency & Reliability
Streamlines mutation detection with high sensitivity, aiding in timely adjustments to treatment strategies.
Workflow
Ordering Information
|
Catalog No. |
Product Name |
Specification |
Description |
|
121035048 |
BCL2 Gene Mutations Digital PCR Detection Kit |
48r |
Chip matched |
|
121034048 |
BTK/ PLCG2 Gene Mutations Digital PCR Detection Kit |
48r |
Chip matched |
|
121025048 |
MYD88 L265P and CXCR4 S338X Mutations Digital PCR Detection Kit |
48r |
Chip matched |
|
121026048 |
MYD88 L265P and CD79b Y196X Mutations Digital PCR Detection Kit |
48r |
Chip matched |
We have a variety of reference materials available, including colour brochures, technical guides, professional literature and operation videos. If you need to consult or obtain relevant materials, please fill in the information below to contact us.